🫀 Narayana Health FY25: ₹710 Cr Profit, ₹34.71 EPS – Healthy Margins, Healthy Jokes, and Still Undervalued?

CMP ₹1,730 | FY25 PAT ₹710 Cr | EPS ₹34.71 | Revenue ₹5,224 Cr | P/E ~49.8x | EBITDA Margin: 22.2%

📌 At a Glance

Narayana Hrudayalaya — India’s discount-heart-surgery kingpin — just pulled off one of the cleanest hospital earnings of FY25:

• 🏥 Revenue up 14.5% YoY
• 💰 PAT up 18.4% YoY
• 🧾 EPS ₹34.71
• 🧮 P/E: ~50x (expensive, but maybe deserved)
• 🏗️ Capex ~₹384 Cr
• 💸 Final dividend: ₹5/share
• 🧠 Patient volumes up, ARPOB up, and even Cayman Islands business glowing like a post-transplant miracle

But CMP ₹1,730 is pricing in perfection. Let’s see if it’s healthy enough to justify it.

📊 Q4 FY25 vs Q4 FY24